Thank you, Don, and good morning, everyone. I'll start by covering our first quarter results before walking you through the rationale behind our updated outlook for the rest of 2024. I'll begin on Slide 4 with our revenues. We delivered $94.5 million of revenue in Q1, which translates into 107% growth year-over-year and 12% growth quarter-over-quarter. This was an all-time company quarterly record and reflects an annual run rate of $378 million. This is already higher than our $350 million revenue guidance of 2024 called for. And it was achieved by prioritizing aerogel production in Rhode Island for thermal barrier production and operating our part assembly plants in Mexico on a schedule that enabled higher productivity. Our Energy Industrial revenue was $29.1 million, a decrease of 14%, year-over-year and a 7% decrease quarter-over-quarter. $14.6 million was delivered through our external manufacturing facility, which has ramped up meaningfully and is now qualified to produce 85% of our revenue mix. We are not concerned by this temporary squeeze in supply and still expect to deliver over $150 million of revenues in 2024 in this segment. As we previously mentioned, our energy business is sold out. And even though the Q1 EV thermal barrier demand squeezed supply for this segment more than expected, our business is now geared in a way where revenue in either segment is just as accretive to gross profit. EV thermal barrier revenue of $65.4 million was up 459% year-over-year and 24% quarter-over-quarter, reflecting the consistent volumes for Toyota and accelerating volume in GM's production of Ultium platform-based electric vehicles, along with the launch of production parts for Scania. Next, I'll provide a summary of our main expenses. Material expenses of $28.1 million for the quarter made up 30 percentage points of sales, a 3 percentage point, improvement quarter-over-quarter. We continue to be pleasantly surprised here as our team continues managing these costs in an environment where, although, the cost of some raw materials provides relief, the logistics of feeding our value chain continued getting more complicated. We remain vigilant with the goal of ensuring that we can keep these below 40 percentage points of sales reliably and prefer to continue conservatively planning with this as our target or long-term North Star. Conversion costs, which we describe as all production costs required to convert raw materials into finished goods, were of $31.2 million or 33 percentage points of sales in Q1. These costs include all elements of direct labor, manufacturing overhead, factory supplies, rent, insurance, utilities, process logistics, quality and inspection. These results reflect a slight increase compared to conversion costs in Q4 of last year, which were 31 percentage points of sales. This is mostly due to product mix as the portion of these costs in EV thermal barriers is higher than it is in our Energy Industrial products. As previously mentioned, our long-term target for these costs at a meaningfully higher revenue run rate is of 20 to 25 percentage points of sales. So we aren't done managing these. The continuation of our work increasing the uptime of our equipment in Mexico, introducing further automation at a faster pace, along with some recent upgrades in aerogel production is paying off. And we still got more opportunity for improvement. Our operations team is not done rightsizing our manufacturing fixed cost structure. So this is where we can continue scaling more efficiently. In Q1, company-level gross profit margins were 37% and our gross profit of $35.1 million is a $30.1 million improvement over our gross profit of $5.1 million during the same quarter of last year. Our Energy Industrial segment delivered $11.6 million of gross profit or a 30% year-over-year increase on lower revenues. In EV thermal barriers, we delivered $23.6 million of gross profit in Q1. If we compare this quarter with Q4 of last year, our EV thermal barrier gross profit improved by $3.8 million on incremental revenue of $12.8 million. This incremental fall-through would have been better without a few onetime charges of obsolete inventory and equipment related to customer-driven engineering changes that we implemented in the quarter. The benefit of those changes and the anticipated reimbursement from customers on a significant portion of these charges will likely be reflected later in the year. At this time last year, our EV thermal barrier segment still operated at a gross loss of $3.8 million on $11.7 million of revenue. Now that we ran it at a $65.4 million quarterly revenue run rate, the comparison to $23.6 million of gross profit in Q1 of 2024 doesn't even seem relevant. The resulting gross profit margins during the quarter were 40% and 36% for our Energy Industrial and EV thermal barrier segments, respectively. Operating expenses, which are sized for our near-term projected annual revenue capacity of over $650 million, were $32.7 million in Q1. This would have actually been down quarter-over-quarter instead of up by about $4.9 million without a couple of meaningful onetime items. The first one is $2.7 million, driven by our team developing the second generation of our automated encapsulation equipment for prismatic cells, faster than we could install and launch the first generation, leading to a write-down of the first-generation equipment. The second one is the $2.2 million cancellation of the management's restricted performance shares award on March 6 of this year. Without these 2 items, our OpEx would have been close to the $110 million annual OpEx run rate level that we've been communicating as our North Star and guideline and the gearing of our company. And we'll continue managing around this level opportunistically increasing it as needed for performance pay, R&D opportunities and to drive incremental demand only. Our team continues to revisiting every key company process and implementing new systems with the intent of bolstering our capabilities, reducing fixed costs and maintaining our OpEx at around this level in order to continue driving scale and efficiency. Putting these elements together, our adjusted EBITDA was $12.9 million in Q1 compared to negative $13.9 million during the same period last year, resulting in a $24.5 million year-over-year reduction in our EBITDA loss. As a reminder, we define adjusted EBITDA as net income or loss before interest, taxes, depreciation, amortization, stock-based compensation expenses and other items that we do not believe are indicative of our core operating performance. In Q1, these adjustments were limited to $4.7 million of stock-based compensation, $1.4 million of interest income and $3.5 million of interest and financing-related expenses. Our net loss in Q1 decreased to $1.8 million or $0.02 per share versus a net loss of $16.8 million or $0.24 per share in the same quarter of 2023. Next, I'll turn to cash flow and our balance sheet. Cash used in operations of $17.7 million reflected our adjusted EBITDA of $12.9 million, other noncash charges of $5.2 million, interest income of $1.4 million, offset by cash used for working capital of $37.2 million. The key items that resulted in the usage of working capital were an increase in accounts receivable and inventory, offset by an increase in accounts payable, prepaid and accrued expenses. Our capital expenditures during the quarter were of $25.9 million. These put our operating cash needs for the quarter at $43.6 million. As we work our way through Q2, we're focused on reducing our working capital needs and freeing up cash by reducing our raw material inventories in what is now a more stable procurement environment and staying on top of our accounts receivable. We actually reduced our raw material inventories by $5 million during the quarter. And there's an element of seasonality to working capital in our business as we prepaid for the year's insurance costs and pay down our accrued expenses related to performance pay for the previous year in Q1. In Q1, we spent $8.1 million slowly advancing progress to fully enclose all the main structures at Plant II and temperature control the main production area. To date, we have incurred $287.9 million and cumulative capital expenses through the end of the first quarter towards Plant II in Georgia to position the project for a potential restart of construction in the fourth quarter of 2024 and only spent $17.8 million on other CapEx that will enable the ramp here of the second half of 2024 and potentially 2025. Our financing activities in the quarter included the $5.3 million sale-leaseback of a range of assets in Rhode Island and our labs in the Boston area. We believe that there are opportunities to continue funding our CapEx in the U.S. in this way and are currently exploring options to fund our investments in Mexico in a similar fashion at a relatively attractive cost of capital. We ended the quarter with $101.5 million of cash and shareholders' equity of $488.9 million. We continue meaningfully working our way through the due diligence and term sheet negotiation phase with the U.S. Department of Energy's Loan Programs Office as part of our application to fund the remaining construction costs of Plant II through a loan pursuant to the DOE's Advanced Technology Vehicle Manufacturing or ATVM loan program. In the appendix, we have a graphic of the different phases of the DOE's application steps and details on the workstreams that make up the due diligence and term sheet negotiation phase. We believe that understanding the structure and terms of this financing enables us to continue working in parallel to ensure that we're capitalized to fund a potentially faster than expected with very profitable near-term ramp in our business. Our top-of-mind options include increasing our usage of capital leases, asset-backed loans, our revolving line of credit, akin to what we had in 2022 and other relatively inexpensive debt options that are now available to us given the recent and expected near-term performance. Now, I'll turn over to Slide 5 and walk you through our thinking behind the updated outlook for the year. When we framed out our revenue outlook for 2024, we were running on limited information and the historical track record of our customers' ability to ramp up production in the prior year. Now as we are seeing an initial ramp, we expect General Motors to produce at least 200,000 EVs in 2024 and enable our EV thermal barrier business to deliver over $230 million of revenue in combination with Toyota, some initial Scania volumes and prototype sales. This acceleration of GM's revenues is likely to continue into Q2 and Q3, but can very well settle in Q4 as the initial sell-through of Ultium based vehicles informs GM's production schedules. We've seen some investors attempt to connect our customers' volume plans to our revenue expectations. And we strongly advise against this, as there's a significant delay of weeks or even months for a finished EV thermal barrier part that we invoice customers for to end up in a produced vehicle. This delay is even longer for a sold vehicle. We've added Slide 11 in the appendix of this presentation to illustrate this. And we recommend that you study it and reach out to Neal if you have any questions. There's plenty of evidence that General Motors established brands with long-running customer loyalty, combined with the size and scope of its distribution scale and the appeal of the recently launched nameplates can drive over 200,000 units of EV sales in 2024. This is well below what we believe is GM's fair share of the EV market. But nonetheless, we'll be monitoring dealer inventory levels to better inform our next guidance update and further frame up our view of what Q3 and Q4 demand could look like. For reference, in the center of Slide 5, we have a chart that shows IHS' expectations for what GM's Ultium production ramp looks like in 2024 to achieve an expected 279,000 units. While time will tell whether 279,000 units is the right production expectation for 2024, the distribution of volume across the 4 quarters of 2024 more closely matches our expectations. Lastly, on the right side of Slide 5, one can see how we expect the transition of supply from our external manufacturing facility within the Energy Industrial segment to occur. In the second half of 2024, we expect our aerogel plant in Rhode Island to mainly be focused on aerogel for EV thermal barriers. And with our external manufacturing facility starting to deliver subsea products in Q2, we remain confident on our ability to deliver over $150 million of revenues in this segment. Turning over to Slide 6. Combining both segments results in a total revenue outlook of at least $380 million, which again would be a 59% year-over-year increase from our revenues in 2023 and a 9% increase over our prior revenue baseline for 2024. In my mind, this translates into a 25% improvement of our year-over-year growth outlook. With this revenue baseline, we believe that we can deliver over $11 million of operating income in 2024, which assuming D&A of around $30 million and stock-based compensation of $14 million would translate into over $55 million of adjusted EBITDA. This is an 83% improvement over our prior baseline EBITDA outlook, demonstrating our ability to scale profitably without relying on outsized revenue growth. Our updated 2024 EBITDA outlook continues considering some potential headwinds to our near-term profitability, such as the cost of new launches, higher part/prototype sales, engineering changes that could lead to inventory obsolescence and expedited freight costs driven by the start-stop nature of some of the nameplates in our thermal barrier demand. We could also opportunistically decide to add OpEx to continue advancing our R&D in key areas and accelerate the development of our technical sales capabilities and fund new program launches. As we reintroduced the rest of our Energy Industrial products, a mix that includes these products will initially impact gross profit in this segment as well. On the flip side, if additional demand is truly there, we expect a disproportionate amount of it to flow to our bottom line. And our team will continue reducing our fixed costs, increasing our production yields, our uptime and driving the right Energy Industrial pricing and mix. Continuing with the rest of our 2024 outlook, $55 million of positive EBITDA would translate into net income of over $2 million or $0.03 per share, assuming a share count of 76.5 million shares. Delivering positive net income is a meaningful milestone that motivates all of us at Aspen. Our CapEx without including Plant II is expected to remain at $50 million for the year. This is for equipment to fund additional productivity gains at our Aerogel plant in Rhode Island, along with equipping our operations in Mexico with the tooling to ramp up our park production capacity in 2025. We are not planning to spend more than $30 million advancing the construction of Plant II in Georgia during the first half of the year to ensure that the site is advanced enough to preserve all of our investments made to date and to enable the potential reacceleration of construction in the second half of the year. The team's ability to reduce the, spend in Q1 reaffirms that the $30 million spend target here is still appropriate. On the right side of Slide 6, before I hand the call back to Don, I think that it's worth pausing and taking stock of the operational and financial journey that our team has been on over the past 15 months. Basic metrics of revenue growth, gross margins, EBITDA and operating income that has to be up and to the right are getting closer to where we need them to be. These results are driven by the consistent execution of a plan that was put in place at a fixed cost level in the fall of 2022 and at a capital investment level in the spring of last year. Thanks to this. We are on a path where we can now scale revenues profitably and the near-term outlook for 2024 is bright. Nonetheless, we remain cautious about the broader long-term industry dynamics while continuing to manage our costs and selectively optimizing our balance sheet. We remain highly motivated and energized by the idea of continuing to advance our level of sophistication as we make the most of the opportunity that we have in front of us. We will do this without forgetting the most important of all things, our cost of capital. And with that, I'm happy to hand the call back to Don. Thank you, everyone.